HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions
| Autor: | Emma Kim, John W. Frew, Ian McCrossin |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Cost effectiveness Cost-Benefit Analysis MEDLINE Dermatology HLA-B15 Antigen Risk Assessment 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine medicine Humans Mass Screening Genetic Testing Drug reaction South east asian Asia Southeastern business.industry Haplotype Australia Carbamazepine 030104 developmental biology Haplotypes Stevens-Johnson Syndrome 030220 oncology & carcinogenesis Anticonvulsants Risk assessment business Administration (government) medicine.drug |
| Zdroj: | Australasian Journal of Dermatology. 59:245-246 |
| ISSN: | 0004-8380 |
| DOI: | 10.1111/ajd.12754 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text